The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam [version 1; peer review: 2 approved]

The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam [version 1; peer review: 2 approved]

Background: Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, because of their superior efficacy, excellent side...

Full description

Bibliographic Details
Main Authors: Huyen Anh Nguyen, Graham S. Cooke, Jeremy N. Day, Barnaby Flower, Le Thanh Phuong, Trinh Manh Hung, Nguyen Thanh Dung, Dao Bach Khoa, Le Manh Hung, Evelyne Kestelyn, Guy E. Thwaites, Nguyen Van Vinh Chau, SEARCH Investigators, Hugo C. Turner
Format: Article
Language:English
Published: Wellcome 2019-09-01
Series:Wellcome Open Research
Online Access:https://wellcomeopenresearch.org/articles/4-129/v1

Internet

https://wellcomeopenresearch.org/articles/4-129/v1

Similar Items